Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content
Full access
Articles
Published Online: 16 December 2019

Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development

Abstract

Objective:

Different cognitive development histories in schizophrenia may reflect variation across dimensions of genetic influence. The authors derived and characterized cognitive development trajectory subgroups within a schizophrenia sample and profiled the subgroups across polygenic scores (PGSs) for schizophrenia, cognition, educational attainment, and attention deficit hyperactivity disorder (ADHD).

Methods:

Demographic, clinical, and genetic data were collected at the National Institute of Mental Health from 540 schizophrenia patients, 247 unaffected siblings, and 844 control subjects. Cognitive trajectory subgroups were derived through cluster analysis using estimates of premorbid and current IQ. PGSs were generated using standard methods. Associations were tested using general linear models and logistic regression.

Results:

Cluster analyses identified three cognitive trajectory subgroups in the schizophrenia group: preadolescent cognitive impairment (19%), adolescent disruption of cognitive development (44%), and cognitively stable adolescent development (37%). Together, the four PGSs significantly predicted 7.9% of the variance in subgroup membership. Subgroup characteristics converged with genetic patterns. Cognitively stable individuals had the best adult clinical outcomes and differed from control subjects only in schizophrenia PGSs. Those with adolescent disruption of cognitive development showed the most severe symptoms after diagnosis and were cognitively impaired. This subgroup had the highest schizophrenia PGSs and had disadvantageous cognitive PGSs relative to control subjects and cognitively stable individuals. Individuals showing preadolescent impairment in cognitive and academic performance and poor adult outcome exhibited a generalized PGS disadvantage relative to control subjects and were the only subgroup to differ significantly in education and ADHD PGSs.

Conclusions:

Subgroups derived from patterns of premorbid and current IQ showed different premorbid and clinical characteristics, which converged with broad genetic profiles. Simultaneous analysis of multiple PGSs may contribute to useful clinical stratification in schizophrenia.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 298 - 307
PubMed: 31838871

History

Received: 22 May 2019
Revision received: 6 September 2019
Accepted: 23 September 2019
Published online: 16 December 2019
Published in print: April 01, 2020

Keywords

  1. Schizophrenia
  2. Cognition
  3. Polygenic Score
  4. Premorbid IQ
  5. Genetics
  6. Developmental Trajectory

Authors

Details

Dwight Dickinson, Ph.D., J.D. [email protected]
Clinical and Translational Neuroscience Branch, NIMH, Bethesda, Md.
Sofia R. Zaidman, B.A.
Clinical and Translational Neuroscience Branch, NIMH, Bethesda, Md.
Evan J. Giangrande, M.A.
Clinical and Translational Neuroscience Branch, NIMH, Bethesda, Md.
Daniel P. Eisenberg, M.D.
Clinical and Translational Neuroscience Branch, NIMH, Bethesda, Md.
Michael D. Gregory, M.D.
Clinical and Translational Neuroscience Branch, NIMH, Bethesda, Md.
Karen F. Berman, M.D.
Clinical and Translational Neuroscience Branch, NIMH, Bethesda, Md.

Notes

Send correspondence to Dr. Dickinson ([email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Funding Information

Division of Intramural Research, National Institute of Mental Health: NCT 95-M-0150
Supported with funding from the Division of Intramural Research Programs, NIMH, to programs within the NIMH Clinical and Translational Neuroscience Branch (Dr. Berman, principal investigator), clinical study number NCT 95-M-0150 and annual report number MH002652-25.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share